Clinical Trial Update: A Safety and Efficacy Study of Oral Dimebon in Patients With Mild-To-Moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety and efficacy of oral dimebon (latrepirdine) in patients with mild-to-moderate Alzheimer's disease has completed, with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Dimebon (latrepirdine)

Snippet

Sponsor: Medivation, Inc. | Conditions: Alzheimer's Disease | Phase 3 | Status: COMPLETED